IRIS
MAZZINI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.867
NA - Nord America 4.587
AS - Asia 3.468
SA - Sud America 511
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 190
OC - Oceania 4
Totale 13.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.420
RU - Federazione Russa 1.329
SG - Singapore 1.235
IE - Irlanda 856
IT - Italia 793
CN - Cina 723
DE - Germania 492
HK - Hong Kong 457
VN - Vietnam 429
BR - Brasile 382
SE - Svezia 370
FR - Francia 226
UA - Ucraina 216
BD - Bangladesh 160
FI - Finlandia 137
GB - Regno Unito 127
BJ - Benin 101
IN - India 96
KR - Corea 96
CA - Canada 82
JP - Giappone 48
PL - Polonia 48
NL - Olanda 47
MX - Messico 46
AR - Argentina 44
AT - Austria 41
ID - Indonesia 38
ZA - Sudafrica 38
TR - Turchia 36
CZ - Repubblica Ceca 29
IQ - Iraq 28
ES - Italia 27
IR - Iran 27
BE - Belgio 24
EE - Estonia 24
EC - Ecuador 18
CO - Colombia 17
LT - Lituania 17
DK - Danimarca 15
CL - Cile 14
JM - Giamaica 13
JO - Giordania 13
RO - Romania 13
DZ - Algeria 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
DO - Repubblica Dominicana 8
MA - Marocco 8
PK - Pakistan 8
TN - Tunisia 8
VE - Venezuela 8
CH - Svizzera 7
PE - Perù 7
PH - Filippine 7
TH - Thailandia 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
GR - Grecia 5
KE - Kenya 5
MY - Malesia 5
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
LV - Lettonia 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
UY - Uruguay 4
CR - Costa Rica 3
EG - Egitto 3
EU - Europa 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GD - Grenada 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
SI - Slovenia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
Totale 13.616
Salva come PNG Salva come JPEG
Città #
Dublin 851
Hong Kong 452
San Jose 434
Singapore 433
Council Bluffs 372
Ashburn 354
Jacksonville 351
Beijing 263
Los Angeles 165
Columbus 164
Moscow 160
Dearborn 157
Ho Chi Minh City 138
Lauterbourg 129
Chandler 122
Cotonou 101
Seoul 91
Buffalo 84
Novara 84
New York 79
Hanoi 78
Munich 76
Lawrence 72
Princeton 72
Wilmington 70
Dallas 68
Santa Clara 65
Piemonte 61
Rome 55
Milan 54
Turin 54
Orem 51
San Mateo 50
Ann Arbor 49
Bremen 48
São Paulo 45
Helsinki 43
Houston 37
Boardman 36
Frankfurt am Main 35
Mülheim 34
Warsaw 33
Tokyo 32
Falkenstein 31
Nuremberg 29
Denver 26
Montreal 25
Brno 24
Brooklyn 24
Chicago 24
Mexico City 24
Stockholm 24
Strasbourg 24
Toronto 24
Chennai 23
Johannesburg 23
Phoenix 23
Redondo Beach 23
The Dalles 23
Vienna 21
Amsterdam 19
Atlanta 19
London 19
Brussels 18
Tianjin 18
Andover 17
Nanjing 17
Jakarta 15
Rio de Janeiro 15
Seattle 15
Vercelli 15
Ankara 14
Da Nang 14
Guangzhou 14
Haiphong 14
Hải Dương 14
Manchester 14
Monmouth Junction 14
San Francisco 14
Turku 14
Woodbridge 14
Boston 13
Hangzhou 13
Philadelphia 13
Poplar 13
Zanjan 13
Amman 12
Hillsboro 12
Kunming 11
Tornaco 11
Baghdad 10
Biên Hòa 10
Quận Bình Thạnh 10
St Louis 10
Villadossola 10
Kocmyrzów 9
Ottawa 9
Charlotte 8
Curitiba 8
Dhaka 8
Totale 7.147
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 254
Retrospective observational study on the use of acetyl-L-carnitine in ALS 194
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 184
Advances in stem cell therapy for amyotrophic lateral sclerosis 183
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 168
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 161
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 161
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 149
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 146
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 142
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 136
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 134
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 134
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 133
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 131
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 130
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 130
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 126
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 125
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 123
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 123
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 122
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 120
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 120
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 119
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 118
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 118
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 117
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 116
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 116
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 115
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 114
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 114
The multistep hypothesis of ALS revisited: The role of genetic mutations 114
Extensive genetics of ALS: a population-based study in Italy. 113
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 113
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 111
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 109
Cognitive impairment across ALS clinical stages in a population-based cohort 108
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 107
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 105
null 105
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 104
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis 104
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 102
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 101
Autologous Stem Cells Transplantation in Amyotrophic Lateral Sclerosis: A Phase I Clinical Trial 101
Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis 100
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 100
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 99
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 99
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 98
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 98
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 98
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 98
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 97
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 97
Transplantation of mesenchymal stem cells in ALS. 96
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 96
A rare case of conjugal amyotrophic lateral sclerosis. 96
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 96
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 95
ATXN-2 CAG repeat expansions are interrupted in ALS patients 93
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 92
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 92
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 92
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 92
Authors' response to a letter from Dr. Esquinas. 90
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 89
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 89
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease 87
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 86
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 86
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 86
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 85
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 85
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 85
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 84
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 84
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 83
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 83
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia 83
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 83
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 83
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 82
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 81
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 81
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 81
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 81
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 80
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 79
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 79
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort 78
Identification of Transcriptomic Differences in Induced Pluripotent Stem Cells and Neural Progenitors from Amyotrophic Lateral Sclerosis Patients Carrying Different Mutations: A Pilot Study 77
VPS54 genetic analysis in ALS Italian cohort 77
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 77
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 76
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 76
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis 76
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 76
Totale 10.705
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022561 0 10 57 70 27 10 19 14 46 18 152 138
2022/20231.702 87 84 61 25 112 121 53 81 927 21 92 38
2023/2024644 59 41 78 33 101 20 94 9 11 7 60 131
2024/20252.099 45 44 122 44 39 235 136 212 405 207 171 439
2025/20266.485 327 255 392 844 700 462 841 1.010 419 490 452 293
2026/2027839 355 484 0 0 0 0 0 0 0 0 0 0
Totale 13.891